Risk Factors and Outcomes in Redo Coronary Artery Bypass Grafting

Michele Gallo1, Jaimin R Trivedi1, Gretel Monreal1

  • 1University of Louisville School of Medicine, Department of Cardiovascular and Thoracic Surgery, Louisville, KY, USA.

Insights

Reoperative coronary artery bypass grafting (redo-CABG) has comparable in-hospital mortality and long-term survival to first-time CABG. Prior percutaneous coronary intervention (PCI) and atherosclerotic risk factors predict the need for redo-CABG, which requires more blood products.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Interventional Cardiology

Background:

  • Reoperative coronary artery bypass grafting (redo-CABG) has decreased, with increased use of percutaneous coronary intervention (PCI).
  • Understanding risk factors and outcomes for redo-CABG is crucial for patient management.
  • This study compares redo-CABG with first-time CABG.

Purpose of the Study:

  • To evaluate risk factors for redo-CABG.
  • To compare in-hospital mortality between first-time CABG and redo-CABG.
  • To assess long-term survival after redo-CABG versus first-time CABG.

Main Methods:

  • Retrospective study of 2,581 first-time CABG and 132 redo-CABG patients (2009-2015).
  • Logistic regression identified risk factors for redo-CABG.
  • Propensity matching compared in-hospital morbidity and long-term mortality.

Main Results:

  • Prior PCI, dyslipidemia, diabetes, and hypertension were risk factors for redo-CABG.
  • No significant baseline differences after propensity matching.
  • Comparable in-hospital mortality (3.1% redo-CABG vs. 2.1% first-time CABG) and 5-year survival (85% redo-CABG vs. 93% first-time CABG).
  • Redo-CABG required significantly more blood products.

Conclusions:

  • Prior PCI and atherosclerotic disease risk factors predict redo-CABG.
  • Redo-CABG necessitates increased blood product usage.
  • In-hospital mortality and long-term survival are comparable between redo-CABG and first-time CABG after propensity matching.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358